Scilex Holding Company

Scilex Holding Company develops and markets non-opioid pharmaceutical products for acute and chronic pain, with a portfolio that includes ZTlido® for topical pain relief, Elyxyb® oral solution for migraine, and Gloperba® for gout management. The company is expanding its pipeline of non-opioid pain medicines while pursuing broader strategic initiatives in capital allocation and digital assets, including recent investments in blockchain infrastructure. Scilex operates as a revenue-generating specialty pharma business with a dual focus on pain management and emerging financial strategies that diversify its long-term growth trajectory.